Stock Comparison
ABBV vs GSK
AbbVie Inc and GlaxoSmithKline PLC ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$105.17B
P/E (TTM)
123.6
14.0
Forward P/E
17.8
22.1
Price/Sales
7.1
3.2
Price/Book
50.5
4.5
EV/EBITDA
30.2
9.4
Dividend Yield
2.77%
3.43%
Profitability
Net Margin
5.79%
17.80%
Operating Margin
32.20%
36.30%
Return on Equity
62.30%
40.90%
Return on Assets
10.00%
10.00%
Growth (YoY)
Revenue Growth
12.40%
1.50%
Earnings Growth
-46.20%
8.40%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$60.65
52-Week Low
$176.02
$34.17
Analyst Target
$254.38
$56.63
Compare ABBV and GSK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.